Literature DB >> 18075949

Auditory dysfunction in traumatic brain injury.

Henry L Lew1, James F Jerger, Sylvia B Guillory, James A Henry.   

Abstract

Effective communication is essential for successful rehabilitation, especially in patients with traumatic brain injury (TBI). The authors examined the prevalence and characteristics of auditory dysfunction in patients with TBI who were admitted to a Department of Veterans Affairs TBI inpatient unit before and after the onset of Operation Iraqi Freedom (OIF). In order to delineate the characteristics of the auditory manifestations of patients who had sustained blast-related (BR) TBI, we reviewed the medical records of 252 patients with TBI and categorized them according to admission date, either before (Group I, n = 102) or after (Group II, n = 150) the onset of OIF. We subdivided Group II into non-blast-related (NBR) and BR TBI; no subjects in Group I had BR TBI. We found that admissions for TBI have increased 47% since the onset of OIF. In Group I, 28% of patients with TBI complained of hearing loss and 11% reported tinnitus. In Group II-NBR (n = 108), 44% complained of hearing loss and 18% reported tinnitus. In Group II-BR (n = 42), 62% complained of hearing loss and 38% reported tinnitus. Sensorineural loss was the most prevalent type of hearing loss in Group II-BR patients. In light of the high prevalence of hearing loss and tinnitus in this growing population of returning soldiers, we need to develop and implement strategies for diagnosis and management of these conditions.

Entities:  

Mesh:

Year:  2007        PMID: 18075949     DOI: 10.1682/jrrd.2007.09.0140

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  32 in total

Review 1.  Neurological effects of blast injury.

Authors:  Ramona R Hicks; Stephanie J Fertig; Rebecca E Desrocher; Walter J Koroshetz; Joseph J Pancrazio
Journal:  J Trauma       Date:  2010-05

2.  Blast-induced tinnitus and hearing loss in rats: behavioral and imaging assays.

Authors:  Johnny C Mao; Edward Pace; Paige Pierozynski; Zhifeng Kou; Yimin Shen; Pamela VandeVord; E Mark Haacke; Xueguo Zhang; Jinsheng Zhang
Journal:  J Neurotrauma       Date:  2011-11-22       Impact factor: 5.269

3.  Brainstem Evoked Potential Indices of Subcortical Auditory Processing After Mild Traumatic Brain Injury.

Authors:  Kathy R Vander Werff; Brian Rieger
Journal:  Ear Hear       Date:  2017 Jul/Aug       Impact factor: 3.570

4.  Intracochlear pressure measurements during acoustic shock wave exposure.

Authors:  Nathaniel T Greene; Mohamed A Alhussaini; James R Easter; Theodore F Argo; Tim Walilko; Daniel J Tollin
Journal:  Hear Res       Date:  2018-05-19       Impact factor: 3.208

5.  Age-related changes in envelope-following responses at equalized peripheral or central activation.

Authors:  Jesyin Lai; Alexandra L Sommer; Edward L Bartlett
Journal:  Neurobiol Aging       Date:  2017-06-24       Impact factor: 4.673

6.  Sensory coding and cognitive processing of sound in Veterans with blast exposure.

Authors:  Scott Bressler; Hannah Goldberg; Barbara Shinn-Cunningham
Journal:  Hear Res       Date:  2016-11-02       Impact factor: 3.208

7.  Auditory and Cognitive Factors Associated with Speech-in-Noise Complaints following Mild Traumatic Brain Injury.

Authors:  Eric C Hoover; Pamela E Souza; Frederick J Gallun
Journal:  J Am Acad Audiol       Date:  2017-04       Impact factor: 1.664

Review 8.  Neuropathology of explosive blast traumatic brain injury.

Authors:  John Magnuson; Fabio Leonessa; Geoffrey S F Ling
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

9.  Preliminary findings of cortical thickness abnormalities in blast injured service members and their relationship to clinical findings.

Authors:  D F Tate; G E York; M W Reid; D B Cooper; L Jones; D A Robin; J E Kennedy; J Lewis
Journal:  Brain Imaging Behav       Date:  2014-03       Impact factor: 3.978

Review 10.  Blast-induced hearing loss.

Authors:  Kunio Mizutari
Journal:  J Zhejiang Univ Sci B       Date:  2017-10-18       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.